Clinical trial
The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and…
NCT00215267 · DBL -Institute for Health Research and Development, Other · Completed
Key facts
| NCT number | NCT00215267 |
|---|---|
| Title | The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda |
| Official title | The Effect of One Versus Two Praziquantel Treatments on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria in Uganda |
| Lead sponsor | DBL -Institute for Health Research and Development, Other |
| Collaborators | Ministry of Health, Uganda |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schistosomiasis, Malaria |
| Intervention type | Drug |
| Interventions | praziquantel |
| Enrollment | 540 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 21, 2008 |
| Countries | Uganda |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: